After @ months , in patients receiving eicosapentaenoic acid-docosahexaenoic acid compared with placebo , the decline in creatinine-cystatin C-based GFR was @ less ( @ % confidence interval , @ to @ ; P < @ ) ml/min per @ m ( @ ) ; other comparisons were not statistical significant .